Table 2 eRAPID RCT in systemic cancer treatment: Researcher collected data for secondary outcomes
Data | Description of data | Time point for collection |
|---|---|---|
Treatment and clinical information | • Cancer diagnosis, stage and grade | Initial baseline assessment and reviewed for changes at 18 weeks |
• Age, date of birth | ||
• Baseline data on planned chemotherapy | ||
• Changes to treatment delivery and reason | ||
• Comorbidities | ||
Clinical process- Hospital contacts | • Contacts with the hospital e.g. (unplanned) telephone, appointments, consultations | • Data extracted from medical notes for 18 of study |
• Emergency admissions, acute ward stays and reasons for contacts. | ||
• 3 month prior to 12 month follow-up assessment | ||
Clinical process- Information from general practice | • GP recorded problems/concurrent illnesses | • Data extracted from medical notes for 18 week study period |
• Prescribed medications and reasons for prescription (where available) | ||
• 3 month period prior to 12 month follow-up assessment for subset of participants | ||
IT/System functioning | • Researcher maintained log of IT issues (e.g. server downtime, contacts with study participants reporting IT problems or issues logging into eRAPID) and how these were resolved | Throughout trial |
Treatment and clinical information | • Cancer diagnosis, stage and grade | Initial baseline assessment and reviewed for changes at 18 weeks |
• Age, date of birth | ||
• Baseline data on planned chemotherapy | ||
• Changes to treatment delivery and reason | ||
• Comorbidities | ||
Clinical process- Hospital contacts | • Contacts with the hospital e.g. (unplanned) telephone, appointments, consultations | • Data extracted from medical notes for 18 of study |
• Emergency admissions, acute ward stays and reasons for contacts. | • 3 month prior to 12 month follow-up assessment | |
Clinical process- Information from general practice | • GP recorded problems/concurrent illnesses | • Data extracted from medical notes for 18 week study period |
• Prescribed medications and reasons for prescription (where available) | ||
• 3 month period prior to 12 month follow-up assessment for subset of participants | ||
IT/System functioning | • Researcher maintained log of IT issues (e.g. server downtime, contacts with study participants reporting IT problems or issues logging into eRAPID) and how these were resolved | Throughout trial |